MB Zonnepanelen has been acquired by Tenten Solar
The shareholder of MB Zonnepanelen B.V. has successfully sold the company to Tenten Solar.
MB Zonnepanelen is a rapidly growing company focused on the installation of solar panels. It was founded in 2011 and has witnessed strong growth since then. Over the last couple of years, the company has served over 3,000 clients in both the residential and SME markets.
Tenten Solar, a portfolio company of Quadrum Capital, is a supplier and installer of solar panels and has been present in the solar energy market since 2009. Quadrum Capital is a Dutch private equity firm with an entrepreneurial mentality and strong roots in the east of the Netherlands. It has a wide portfolio of shareholdings in a variety of industries. Earlier transactions with Quadrum Capital include Ace Pharmaceuticals and State of Art.
Oaklins’ team in the Netherlands acted as advisor to the seller in this transaction.
Talk to the deal team
Related deals
Mark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn moreHærup Biogas has been acquired by Gasum
Gasum has entered the Danish biogas market with its acquisition of all shares in Hærup Biogas, which owns and operates a biogas plant in the northern part of mainland Denmark.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more